Satyendra Chandra Tripathi

Employment

• All India Institute of Medical Sciences, Nagpur Associate Professor
  2022 - Present
• All India Institute of Medical Sciences Assistant Professor
  2018 - 2022
• University of Texas MD Anderson Cancer Center Post doc
  2012 - 2018

Education

• All India Institute of Medical Sciences Ph.D.
  2007 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (105)

• Targeted inhibition of NRF2 reduces the invasive and metastatic ability of HIP1 depleted lung cancer cells
  Biochemical and Biophysical Research Communications 2024 DOI: 10.1016/j.bbrc.2024.150676
  +Save
• Huntingtin Interacting Protein-1 expression is regulated via HIF2 axis in Lung Adenocarcinoma
  bioRxiv 2023 DOI: 10.1101/2023.03.27.534427
  +Save
• Passage number of cancer cell lines: Importance, intricacies, and way-forward
  Biotechnology and Bioengineering 2023 DOI: 10.1002/bit.28496
  +Save
• Targeting immune-onco-metabolism for precision cancer therapy
  Frontiers in Oncology 2023 DOI: 10.3389/fonc.2023.1124715
  +Save
• Erratum: Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids (Cell Reports (2022) 39(9), (S2211124722006453), (10.1016/j.celrep.2022.110870))
  Cell Reports 2022 DOI: 10.1016/j.celrep.2022.111044
  +Save
• Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids
  Cell Reports 2022 DOI: 10.1016/j.celrep.2022.110870
  +Save
• Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
  Cancers 2022 DOI: 10.3390/cancers14102543
  +Save
• Targeting the Immuno-Oncology Metabolism in Cancer
  Immuno-Oncology Crosstalk and Metabolism 2022 DOI: 10.1007/978-981-16-6226-3_5
  +Save
• SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.
  Journal of the National Cancer Institute 2021 DOI: 10.1093/jnci/djab183
  +Save
• COVID-19: a review on SARS-CoV-2 origin, epidemiology, virology, clinical manifestations and complications with special emphasis on adverse outcome in Bhopal Gas Tragedy survivor.
  Hormone molecular biology and clinical investigation 2021 DOI: 10.1515/hmbci-2020-0070
  +Save